DK3331873T3 - 4-(3-pyrazolylamino)-benzimidazolderivat som jak1-inhibitor til behandling af kræft - Google Patents

4-(3-pyrazolylamino)-benzimidazolderivat som jak1-inhibitor til behandling af kræft Download PDF

Info

Publication number
DK3331873T3
DK3331873T3 DK16750326.7T DK16750326T DK3331873T3 DK 3331873 T3 DK3331873 T3 DK 3331873T3 DK 16750326 T DK16750326 T DK 16750326T DK 3331873 T3 DK3331873 T3 DK 3331873T3
Authority
DK
Denmark
Prior art keywords
benzimidazold
pyrazolylamino
cancer
derivative
treatment
Prior art date
Application number
DK16750326.7T
Other languages
English (en)
Inventor
Joshua Ryan Clayton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK3331873T3 publication Critical patent/DK3331873T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK16750326.7T 2015-08-04 2016-07-28 4-(3-pyrazolylamino)-benzimidazolderivat som jak1-inhibitor til behandling af kræft DK3331873T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562200684P 2015-08-04 2015-08-04
PCT/US2016/044410 WO2017023672A1 (en) 2015-08-04 2016-07-28 4-(3-pyrazolylamino)-benzimidazole compounds and their use as jak1 inhibitors

Publications (1)

Publication Number Publication Date
DK3331873T3 true DK3331873T3 (da) 2019-08-12

Family

ID=56618268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16750326.7T DK3331873T3 (da) 2015-08-04 2016-07-28 4-(3-pyrazolylamino)-benzimidazolderivat som jak1-inhibitor til behandling af kræft

Country Status (27)

Country Link
US (1) US9556153B1 (da)
EP (1) EP3331873B1 (da)
JP (1) JP6470869B2 (da)
KR (1) KR102032792B1 (da)
CN (1) CN108026076B (da)
AR (1) AR105400A1 (da)
AU (1) AU2016302748B2 (da)
BR (1) BR112017028240B1 (da)
CA (1) CA2990471C (da)
CY (1) CY1121909T1 (da)
DK (1) DK3331873T3 (da)
EA (1) EA033572B1 (da)
ES (1) ES2743499T3 (da)
HR (1) HRP20191227T1 (da)
HU (1) HUE047037T2 (da)
LT (1) LT3331873T (da)
MA (1) MA44383B1 (da)
MD (1) MD3331873T2 (da)
ME (1) ME03451B (da)
MX (1) MX2018001306A (da)
NZ (1) NZ738247A (da)
PL (1) PL3331873T3 (da)
PT (1) PT3331873T (da)
RS (1) RS58974B1 (da)
SI (1) SI3331873T1 (da)
TW (1) TW201718555A (da)
WO (1) WO2017023672A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ748942A (en) 2016-07-14 2020-08-28 Lilly Co Eli Pyrazolylaminobenzimidazole derivatives as jak inhibitors
GB201717260D0 (en) * 2017-10-20 2017-12-06 Galapagos Nv Novel compounds and pharma ceutical compositions thereof for the treatment of inflammatory disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013025628A1 (en) * 2011-08-15 2013-02-21 Ligand Pharmaceuticals Incorporated Janus kinase inhibitor compounds and methods
KR20150008907A (ko) * 2012-06-14 2015-01-23 일라이 릴리 앤드 캄파니 Jak1 및 jak2의 억제제
GB201401086D0 (en) * 2014-01-23 2014-03-12 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Also Published As

Publication number Publication date
BR112017028240A2 (pt) 2018-09-04
EA201792676A1 (ru) 2018-07-31
TW201718555A (zh) 2017-06-01
CN108026076B (zh) 2020-07-10
US20170037034A1 (en) 2017-02-09
AR105400A1 (es) 2017-09-27
JP6470869B2 (ja) 2019-02-13
AU2016302748B2 (en) 2019-02-28
JP2018524384A (ja) 2018-08-30
MA44383B1 (fr) 2019-08-30
AU2016302748A1 (en) 2018-01-04
US9556153B1 (en) 2017-01-31
SI3331873T1 (sl) 2019-08-30
KR20180022966A (ko) 2018-03-06
KR102032792B1 (ko) 2019-10-16
RS58974B1 (sr) 2019-08-30
CA2990471A1 (en) 2017-02-09
ME03451B (me) 2020-01-20
PT3331873T (pt) 2019-09-12
ES2743499T3 (es) 2020-02-19
LT3331873T (lt) 2019-08-26
CA2990471C (en) 2020-01-07
EA033572B1 (ru) 2019-11-06
CY1121909T1 (el) 2020-10-14
WO2017023672A1 (en) 2017-02-09
MX2018001306A (es) 2018-05-17
EP3331873A1 (en) 2018-06-13
EP3331873B1 (en) 2019-06-26
HUE047037T2 (hu) 2020-04-28
NZ738247A (en) 2019-06-28
BR112017028240B1 (pt) 2023-04-11
MA44383A (fr) 2019-01-23
PL3331873T3 (pl) 2019-11-29
CN108026076A (zh) 2018-05-11
HRP20191227T1 (hr) 2019-10-18
MD3331873T2 (ro) 2019-11-30

Similar Documents

Publication Publication Date Title
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3119762T3 (da) Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft
DK3445767T3 (da) Makrocykliske mcl1-inhibitorer til behandling af cancer
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3472167T3 (da) Heterocykliske forbindelser som immunomodulatorer
DK3377488T3 (da) Heterocykliske forbindelser som immunomodulatorer
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3365334T3 (da) Benzolactamforbindelser som proteinkinaseinhibitorer
DK3303348T3 (da) Naphthyridinforbindelser som JAK-kinaseinhibitorer
DK3356345T3 (da) Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
DK3164130T3 (da) Heteroaryle forbindelser anvendelige som inhibatorer af sumo-aktiverende enzym
DK3294738T3 (da) Mono- og disubstituerede indolderivater som inhibitorer af replikation af denguevirus
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3433253T3 (da) Pyrimidinforbindelse som JAK-kinase-inhibitorer
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3350163T3 (da) Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation
DK3313838T3 (da) Polycykliske amidderivater som cdk9-inhibitorer
DK3371165T3 (da) Btk-inhibitor til anvendelse til behandling af kræft
DK3261726T3 (da) Sammensætning til behandling af acne
DK3235819T3 (da) Pyrrolopyrimidinforbindelser, der er anvendelige som JAK-inhibitorer
DK3512857T3 (da) Spiro-bicykliske inhibitorer af menin-mll-interaktion
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande